TAK-242: Advancing TLR4 Inhibition for Translational Immu...
2025-10-21
Explore TAK-242, a selective TLR4 inhibitor, as a transformative tool for dissecting innate-adaptive immune crosstalk, translational immunology, and neuropsychiatric disorder models. This article delivers an advanced, application-focused analysis unavailable elsewhere.